APO Research
Talk to an analyst

APO RESEARCH · REPORT

Erlotinib Generics

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Erlotinib Generics Industry Growth and Trends Forecast to 2032

27 December 2025104 pages

Choose your research edition.

Industry ResearchErlotinib Generics Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Erlotinib Generics Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Erlotinib Generics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Erlotinib Generics Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Erlotinib Generics Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Erlotinib Generics market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Erlotinib Generics is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Erlotinib Generics is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Erlotinib Generics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Erlotinib Generics include Thery Pharm, Shenzhen Salubris Pharmaceuticals, Acebright Pharma, Shandong Loncom Pharma, Jilin Aodong Taonan Pharmaceutical, Hansoh Pharma, Teva, Taj Pharma and Sun Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Erlotinib Generics market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Erlotinib Generics market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Erlotinib Generics market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Erlotinib Generics.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Erlotinib Generics market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Erlotinib Generics Market by Company

Thery Pharm

Shenzhen Salubris Pharmaceuticals

Acebright Pharma

Shandong Loncom Pharma

Jilin Aodong Taonan Pharmaceutical

Hansoh Pharma

Teva

Taj Pharma

Sun Pharmaceutical

Natco Pharma

Mylan

Glenmark Pharmaceuticals

Cipla

Aristopharma

Erlotinib Generics Segment by Type

25mg per Tablet

150mg per Tablet

100mg per Tablet

Erlotinib Generics Segment by Application

Retail Pharmacies

Hospital and Clinic

Other

Erlotinib Generics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Erlotinib Generics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Erlotinib Generics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Erlotinib Generics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Erlotinib Generics manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Erlotinib Generics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 25mg per Tablet Table 2. Major Company of 150mg per Tablet Table 3. Major Company of 100mg per Tablet Table 4. Global Erlotinib Generics Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Erlotinib Generics Sales by Type (2021-2026) & (K Units) Table 6. Global Erlotinib Generics Sales Market Share in Volume by Type (2021-2026) Table 7. Global Erlotinib Generics Sales by Type (2021-2026) & (US$ Million) Table 8. Global Erlotinib Generics Sales Market Share in Value by Type (2021-2026) Table 9. Global Erlotinib Generics Price by Type (2021-2026) & (US$/Unit) Table 10. Global Erlotinib Generics Sales by Type (2027-2032) & (K Units) Table 11. Global Erlotinib Generics Sales Market Share in Volume by Type (2027-2032) Table 12. Global Erlotinib Generics Sales by Type (2027-2032) & (US$ Million) Table 13. Global Erlotinib Generics Sales Market Share in Value by Type (2027-2032) Table 14. Global Erlotinib Generics Price by Type (2027-2032) & (US$/Unit) Table 15. North America Erlotinib Generics Sales by Type (2021-2026) & (K Units) Table 16. North America Erlotinib Generics Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Erlotinib Generics Sales by Type (2021-2026) & (K Units) Table 18. Europe Erlotinib Generics Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Erlotinib Generics Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Erlotinib Generics Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Erlotinib Generics Sales by Type (2021-2026) & (K Units) Table 22. Latin America Erlotinib Generics Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Erlotinib Generics Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Erlotinib Generics Sales by Type (2021-2026) & (US$ Million) Table 25. Erlotinib Generics Industry Trends Table 26. Erlotinib Generics Industry Drivers Table 27. Erlotinib Generics Industry Opportunities and Challenges Table 28. Erlotinib Generics Industry Restraints Table 29. Global Erlotinib Generics Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Erlotinib Generics Revenue Market Share by Company (2021-2026) Table 31. Global Erlotinib Generics Sales by Company (2021-2026) & (K Units) Table 32. Global Erlotinib Generics Sales Share by Company (2021-2026) Table 33. Global Erlotinib Generics Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Erlotinib Generics Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Erlotinib Generics Major Company Production Sites and Headquarters Table 36. Global Erlotinib Generics Company, Product Type & Application Table 37. Global Erlotinib Generics Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Erlotinib Generics by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Erlotinib Generics Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Erlotinib Generics Sales by Region (2021-2026) & (K Units) Table 42. Global Erlotinib Generics Sales Market Share in Volume by Region (2021-2026) Table 43. Global Erlotinib Generics Sales by Region (2021-2026) & (US$ Million) Table 44. Global Erlotinib Generics Sales Market Share in Value by Region (2021-2026) Table 45. Global Erlotinib Generics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Erlotinib Generics Sales by Region (2027-2032) & (K Units) Table 47. Global Erlotinib Generics Sales Market Share in Volume by Region (2027-2032) Table 48. Global Erlotinib Generics Sales by Region (2027-2032) & (US$ Million) Table 49. Global Erlotinib Generics Sales Market Share in Value by Region (2027-2032) Table 50. Global Erlotinib Generics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Erlotinib Generics Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Erlotinib Generics Sales by Application (2021-2026) & (K Units) Table 53. Global Erlotinib Generics Sales Market Share in Volume by Application (2021-2026) Table 54. Global Erlotinib Generics Sales by Application (2021-2026) & (US$ Million) Table 55. Global Erlotinib Generics Sales Market Share in Value by Application (2021-2026) Table 56. Global Erlotinib Generics Price by Application (2021-2026) & (US$/Unit) Table 57. Global Erlotinib Generics Sales by Application (2027-2032) & (K Units) Table 58. Global Erlotinib Generics Sales Market Share in Volume by Application (2027-2032) Table 59. Global Erlotinib Generics Sales by Application (2027-2032) & (US$ Million) Table 60. Global Erlotinib Generics Sales Market Share in Value by Application (2027-2032) Table 61. Global Erlotinib Generics Price by Application (2027-2032) & (US$/Unit) Table 62. North America Erlotinib Generics Sales by Application (2021-2026) & (K Units) Table 63. North America Erlotinib Generics Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Erlotinib Generics Sales by Application (2021-2026) & (K Units) Table 65. Europe Erlotinib Generics Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Erlotinib Generics Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Erlotinib Generics Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Erlotinib Generics Sales by Application (2021-2026) & (K Units) Table 69. Latin America Erlotinib Generics Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Erlotinib Generics Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Erlotinib Generics Sales by Application (2021-2026) & (US$ Million) Table 72. Thery Pharm Company Information Table 73. Thery Pharm Business Overview Table 74. Thery Pharm Erlotinib Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Thery Pharm Erlotinib Generics Product Portfolio Table 76. Thery Pharm Recent Development Table 77. Shenzhen Salubris Pharmaceuticals Company Information Table 78. Shenzhen Salubris Pharmaceuticals Business Overview Table 79. Shenzhen Salubris Pharmaceuticals Erlotinib Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Shenzhen Salubris Pharmaceuticals Erlotinib Generics Product Portfolio Table 81. Shenzhen Salubris Pharmaceuticals Recent Development Table 82. Acebright Pharma Company Information Table 83. Acebright Pharma Business Overview Table 84. Acebright Pharma Erlotinib Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Acebright Pharma Erlotinib Generics Product Portfolio Table 86. Acebright Pharma Recent Development Table 87. Shandong Loncom Pharma Company Information Table 88. Shandong Loncom Pharma Business Overview Table 89. Shandong Loncom Pharma Erlotinib Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Shandong Loncom Pharma Erlotinib Generics Product Portfolio Table 91. Shandong Loncom Pharma Recent Development Table 92. Jilin Aodong Taonan Pharmaceutical Company Information Table 93. Jilin Aodong Taonan Pharmaceutical Business Overview Table 94. Jilin Aodong Taonan Pharmaceutical Erlotinib Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Jilin Aodong Taonan Pharmaceutical Erlotinib Generics Product Portfolio Table 96. Jilin Aodong Taonan Pharmaceutical Recent Development Table 97. Hansoh Pharma Company Information Table 98. Hansoh Pharma Business Overview Table 99. Hansoh Pharma Erlotinib Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Hansoh Pharma Erlotinib Generics Product Portfolio Table 101. Hansoh Pharma Recent Development Table 102. Teva Company Information Table 103. Teva Business Overview Table 104. Teva Erlotinib Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Teva Erlotinib Generics Product Portfolio Table 106. Teva Recent Development Table 107. Taj Pharma Company Information Table 108. Taj Pharma Business Overview Table 109. Taj Pharma Erlotinib Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Taj Pharma Erlotinib Generics Product Portfolio Table 111. Taj Pharma Recent Development Table 112. Sun Pharmaceutical Company Information Table 113. Sun Pharmaceutical Business Overview Table 114. Sun Pharmaceutical Erlotinib Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Sun Pharmaceutical Erlotinib Generics Product Portfolio Table 116. Sun Pharmaceutical Recent Development Table 117. Natco Pharma Company Information Table 118. Natco Pharma Business Overview Table 119. Natco Pharma Erlotinib Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Natco Pharma Erlotinib Generics Product Portfolio Table 121. Natco Pharma Recent Development Table 122. Mylan Company Information Table 123. Mylan Business Overview Table 124. Mylan Erlotinib Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Mylan Erlotinib Generics Product Portfolio Table 126. Mylan Recent Development Table 127. Glenmark Pharmaceuticals Company Information Table 128. Glenmark Pharmaceuticals Business Overview Table 129. Glenmark Pharmaceuticals Erlotinib Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 130. Glenmark Pharmaceuticals Erlotinib Generics Product Portfolio Table 131. Glenmark Pharmaceuticals Recent Development Table 132. Cipla Company Information Table 133. Cipla Business Overview Table 134. Cipla Erlotinib Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 135. Cipla Erlotinib Generics Product Portfolio Table 136. Cipla Recent Development Table 137. Aristopharma Company Information Table 138. Aristopharma Business Overview Table 139. Aristopharma Erlotinib Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 140. Aristopharma Erlotinib Generics Product Portfolio Table 141. Aristopharma Recent Development Table 142. North America Erlotinib Generics Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 143. North America Erlotinib Generics Sales by Country (2021-2026) & (K Units) Table 144. North America Erlotinib Generics Sales Market Share by Country (2021-2026) Table 145. North America Erlotinib Generics Sales Forecast by Country (2027-2032) & (K Units) Table 146. North America Erlotinib Generics Sales Market Share Forecast by Country (2027-2032) Table 147. North America Erlotinib Generics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. North America Erlotinib Generics Market Size by Country (2021-2026) & (US$ Million) Table 149. North America Erlotinib Generics Market Share by Country (2021-2026) Table 150. North America Erlotinib Generics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. North America Erlotinib Generics Market Share Forecast by Country (2027-2032) Table 152. Europe Erlotinib Generics Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 153. Europe Erlotinib Generics Sales by Country (2021-2026) & (K Units) Table 154. Europe Erlotinib Generics Sales Market Share by Country (2021-2026) Table 155. Europe Erlotinib Generics Sales Forecast by Country (2027-2032) & (K Units) Table 156. Europe Erlotinib Generics Sales Market Share Forecast by Country (2027-2032) Table 157. Europe Erlotinib Generics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 158. Europe Erlotinib Generics Market Size by Country (2021-2026) & (US$ Million) Table 159. Europe Erlotinib Generics Market Share by Country (2021-2026) Table 160. Europe Erlotinib Generics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 161. Europe Erlotinib Generics Market Share Forecast by Country (2027-2032) Table 162. Asia-Pacific Erlotinib Generics Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 163. Asia-Pacific Erlotinib Generics Sales by Country (2021-2026) & (K Units) Table 164. Asia-Pacific Erlotinib Generics Sales Market Share by Country (2021-2026) Table 165. Asia-Pacific Erlotinib Generics Sales Forecast by Country (2027-2032) & (K Units) Table 166. Asia-Pacific Erlotinib Generics Sales Market Share Forecast by Country (2027-2032) Table 167. Asia-Pacific Erlotinib Generics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 168. Asia-Pacific Erlotinib Generics Market Size by Country (2021-2026) & (US$ Million) Table 169. Asia-Pacific Erlotinib Generics Market Share by Country (2021-2026) Table 170. Asia-Pacific Erlotinib Generics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 171. Asia-Pacific Erlotinib Generics Market Share Forecast by Country (2027-2032) Table 172. Latin America Erlotinib Generics Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 173. Latin America Erlotinib Generics Sales by Country (2021-2026) & (K Units) Table 174. Latin America Erlotinib Generics Sales Market Share by Country (2021-2026) Table 175. Latin America Erlotinib Generics Sales Forecast by Country (2027-2032) & (K Units) Table 176. Latin America Erlotinib Generics Sales Market Share Forecast by Country (2027-2032) Table 177. Latin America Erlotinib Generics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 178. Latin America Erlotinib Generics Market Size by Country (2021-2026) & (US$ Million) Table 179. Latin America Erlotinib Generics Market Share by Country (2021-2026) Table 180. Latin America Erlotinib Generics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 181. Latin America Erlotinib Generics Market Share Forecast by Country (2027-2032) Table 182. Middle East and Africa Erlotinib Generics Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 183. Middle East and Africa Erlotinib Generics Sales by Country (2021-2026) & (K Units) Table 184. Middle East and Africa Erlotinib Generics Sales Market Share by Country (2021-2026) Table 185. Middle East and Africa Erlotinib Generics Sales Forecast by Country (2027-2032) & (K Units) Table 186. Middle East and Africa Erlotinib Generics Sales Market Share Forecast by Country (2027-2032) Table 187. Middle East and Africa Erlotinib Generics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 188. Middle East and Africa Erlotinib Generics Market Size by Country (2021-2026) & (US$ Million) Table 189. Middle East and Africa Erlotinib Generics Market Share by Country (2021-2026) Table 190. Middle East and Africa Erlotinib Generics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 191. Middle East and Africa Erlotinib Generics Market Share Forecast by Country (2027-2032) Table 192. Key Raw Materials Table 193. Raw Materials Key Suppliers Table 194. Erlotinib Generics Distributors List Table 195. Erlotinib Generics Customers List Table 196. Research Programs/Design for This Report Table 197. Authors List of This Report Table 198. Secondary Sources Table 199. Primary Sources List of Figures Figure 1. Erlotinib Generics Image Figure 2. Global Erlotinib Generics Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Erlotinib Generics Market Size (2021-2032) & (US$ Million) Figure 4. Global Erlotinib Generics Sales (2021-2032) & (K Units) Figure 5. 25mg per Tablet Image Figure 6. Global 25mg per Tablet Sales YoY Growth (2021-2032) & (K Units) Figure 7. 150mg per Tablet Image Figure 8. Global 150mg per Tablet Sales YoY Growth (2021-2032) & (K Units) Figure 9. 100mg per Tablet Image Figure 10. Global 100mg per Tablet Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Erlotinib Generics Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Erlotinib Generics Market Share by Type 2025 VS 2032 Figure 13. North America Erlotinib Generics Sales Market Share in Volume by Type in 2025 Figure 14. North America Erlotinib Generics Sales Market Share in Value by Type in 2025 Figure 15. Europe Erlotinib Generics Sales Market Share in Volume by Type in 2025 Figure 16. Europe Erlotinib Generics Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Erlotinib Generics Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Erlotinib Generics Sales Market Share in Value by Type in 2025 Figure 19. Latin America Erlotinib Generics Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Erlotinib Generics Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Erlotinib Generics Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Erlotinib Generics Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Erlotinib Generics Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Retail Pharmacies Image Figure 26. Global Retail Pharmacies Sales YoY Growth (2021-2032) & (K Units) Figure 27. Hospital and Clinic Image Figure 28. Global Hospital and Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 29. Other Image Figure 30. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 31. Global Erlotinib Generics Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Erlotinib Generics Market Share by Application 2025 VS 2032 Figure 33. North America Erlotinib Generics Sales Market Share in Volume by Application in 2025 Figure 34. North America Erlotinib Generics Sales Market Share in Value by Application in 2025 Figure 35. Europe Erlotinib Generics Sales Market Share in Volume by Application in 2025 Figure 36. Europe Erlotinib Generics Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Erlotinib Generics Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Erlotinib Generics Sales Market Share in Value by Application in 2025 Figure 39. Latin America Erlotinib Generics Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Erlotinib Generics Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Erlotinib Generics Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Erlotinib Generics Sales Market Share in Value by Application in 2025 Figure 43. North America Erlotinib Generics Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. North America Erlotinib Generics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Erlotinib Generics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Erlotinib Generics Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Erlotinib Generics Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Europe Erlotinib Generics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Erlotinib Generics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Erlotinib Generics Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Erlotinib Generics Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Asia-Pacific Erlotinib Generics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Erlotinib Generics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Erlotinib Generics Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Erlotinib Generics Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Latin America Erlotinib Generics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Erlotinib Generics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Erlotinib Generics Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Erlotinib Generics Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Middle East and Africa Erlotinib Generics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Erlotinib Generics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Erlotinib Generics Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Erlotinib Generics Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Erlotinib Generics Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • 25mg per Tablet
  • 150mg per Tablet
  • 100mg per Tablet
Applications
  • Retail Pharmacies
  • Hospital and Clinic
  • Other
Companies covered
  • Thery Pharm
  • Shenzhen Salubris Pharmaceuticals
  • Acebright Pharma
  • Shandong Loncom Pharma
  • Jilin Aodong Taonan Pharmaceutical
  • Hansoh Pharma
  • Teva
  • Taj Pharma
  • Sun Pharmaceutical
  • Natco Pharma
  • Mylan
  • Glenmark Pharmaceuticals
  • Cipla
  • Aristopharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Erlotinib Generics Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Erlotinib Generics Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Erlotinib Generics Market by Type
  6. 1.3.1 25mg per Tablet
  7. 1.3.2 150mg per Tablet
  8. 1.3.3 100mg per Tablet
  9. 1.4 Global Erlotinib Generics Market Size by Type
  10. 1.4.1 Global Erlotinib Generics Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Erlotinib Generics Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Erlotinib Generics Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Erlotinib Generics Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Erlotinib Generics Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Erlotinib Generics Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Erlotinib Generics Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Erlotinib Generics Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Erlotinib Generics Industry Trends
  2. 2.2 Erlotinib Generics Industry Drivers
  3. 2.3 Erlotinib Generics Industry Opportunities and Challenges
  4. 2.4 Erlotinib Generics Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Erlotinib Generics Revenue (2021-2026)
  2. 3.2 Global Top Players by Erlotinib Generics Sales (2021-2026)
  3. 3.3 Global Top Players by Erlotinib Generics Price (2021-2026)
  4. 3.4 Global Erlotinib Generics Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Erlotinib Generics Major Company Production Sites & Headquarters
  6. 3.6 Global Erlotinib Generics Company, Product Type & Application
  7. 3.7 Global Erlotinib Generics Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Erlotinib Generics Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Erlotinib Generics Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Erlotinib Generics Tier 1, Tier 2, and Tier 3
4 Erlotinib Generics Regional Status and Outlook
  1. 4.1 Global Erlotinib Generics Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Erlotinib Generics Historic Market Size by Region
  3. 4.2.1 Global Erlotinib Generics Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Erlotinib Generics Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Erlotinib Generics Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Erlotinib Generics Forecasted Market Size by Region
  7. 4.3.1 Global Erlotinib Generics Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Erlotinib Generics Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Erlotinib Generics Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Erlotinib Generics by Application
  1. 5.1 Erlotinib Generics Market by Application
  2. 5.1.1 Retail Pharmacies
  3. 5.1.2 Hospital and Clinic
  4. 5.1.3 Other
  5. 5.2 Global Erlotinib Generics Market Size by Application
  6. 5.2.1 Global Erlotinib Generics Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Erlotinib Generics Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Erlotinib Generics Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Erlotinib Generics Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Erlotinib Generics Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Erlotinib Generics Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Erlotinib Generics Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Erlotinib Generics Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Thery Pharm
  2. 6.1.1 Thery Pharm Company Information
  3. 6.1.2 Thery Pharm Business Overview
  4. 6.1.3 Thery Pharm Erlotinib Generics Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Thery Pharm Erlotinib Generics Product Portfolio
  6. 6.1.5 Thery Pharm Recent Developments
  7. 6.2 Shenzhen Salubris Pharmaceuticals
  8. 6.2.1 Shenzhen Salubris Pharmaceuticals Company Information
  9. 6.2.2 Shenzhen Salubris Pharmaceuticals Business Overview
  10. 6.2.3 Shenzhen Salubris Pharmaceuticals Erlotinib Generics Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Shenzhen Salubris Pharmaceuticals Erlotinib Generics Product Portfolio
  12. 6.2.5 Shenzhen Salubris Pharmaceuticals Recent Developments
  13. 6.3 Acebright Pharma
  14. 6.3.1 Acebright Pharma Company Information
  15. 6.3.2 Acebright Pharma Business Overview
  16. 6.3.3 Acebright Pharma Erlotinib Generics Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Acebright Pharma Erlotinib Generics Product Portfolio
  18. 6.3.5 Acebright Pharma Recent Developments
  19. 6.4 Shandong Loncom Pharma
  20. 6.4.1 Shandong Loncom Pharma Company Information
  21. 6.4.2 Shandong Loncom Pharma Business Overview
  22. 6.4.3 Shandong Loncom Pharma Erlotinib Generics Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Shandong Loncom Pharma Erlotinib Generics Product Portfolio
  24. 6.4.5 Shandong Loncom Pharma Recent Developments
  25. 6.5 Jilin Aodong Taonan Pharmaceutical
  26. 6.5.1 Jilin Aodong Taonan Pharmaceutical Company Information
  27. 6.5.2 Jilin Aodong Taonan Pharmaceutical Business Overview
  28. 6.5.3 Jilin Aodong Taonan Pharmaceutical Erlotinib Generics Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Jilin Aodong Taonan Pharmaceutical Erlotinib Generics Product Portfolio
  30. 6.5.5 Jilin Aodong Taonan Pharmaceutical Recent Developments
  31. 6.6 Hansoh Pharma
  32. 6.6.1 Hansoh Pharma Company Information
  33. 6.6.2 Hansoh Pharma Business Overview
  34. 6.6.3 Hansoh Pharma Erlotinib Generics Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Hansoh Pharma Erlotinib Generics Product Portfolio
  36. 6.6.5 Hansoh Pharma Recent Developments
  37. 6.7 Teva
  38. 6.7.1 Teva Company Information
  39. 6.7.2 Teva Business Overview
  40. 6.7.3 Teva Erlotinib Generics Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Teva Erlotinib Generics Product Portfolio
  42. 6.7.5 Teva Recent Developments
  43. 6.8 Taj Pharma
  44. 6.8.1 Taj Pharma Company Information
  45. 6.8.2 Taj Pharma Business Overview
  46. 6.8.3 Taj Pharma Erlotinib Generics Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Taj Pharma Erlotinib Generics Product Portfolio
  48. 6.8.5 Taj Pharma Recent Developments
  49. 6.9 Sun Pharmaceutical
  50. 6.9.1 Sun Pharmaceutical Company Information
  51. 6.9.2 Sun Pharmaceutical Business Overview
  52. 6.9.3 Sun Pharmaceutical Erlotinib Generics Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Sun Pharmaceutical Erlotinib Generics Product Portfolio
  54. 6.9.5 Sun Pharmaceutical Recent Developments
  55. 6.10 Natco Pharma
  56. 6.10.1 Natco Pharma Company Information
  57. 6.10.2 Natco Pharma Business Overview
  58. 6.10.3 Natco Pharma Erlotinib Generics Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Natco Pharma Erlotinib Generics Product Portfolio
  60. 6.10.5 Natco Pharma Recent Developments
  61. 6.11 Mylan
  62. 6.11.1 Mylan Company Information
  63. 6.11.2 Mylan Business Overview
  64. 6.11.3 Mylan Erlotinib Generics Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Mylan Erlotinib Generics Product Portfolio
  66. 6.11.5 Mylan Recent Developments
  67. 6.12 Glenmark Pharmaceuticals
  68. 6.12.1 Glenmark Pharmaceuticals Company Information
  69. 6.12.2 Glenmark Pharmaceuticals Business Overview
  70. 6.12.3 Glenmark Pharmaceuticals Erlotinib Generics Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Glenmark Pharmaceuticals Erlotinib Generics Product Portfolio
  72. 6.12.5 Glenmark Pharmaceuticals Recent Developments
  73. 6.13 Cipla
  74. 6.13.1 Cipla Company Information
  75. 6.13.2 Cipla Business Overview
  76. 6.13.3 Cipla Erlotinib Generics Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Cipla Erlotinib Generics Product Portfolio
  78. 6.13.5 Cipla Recent Developments
  79. 6.14 Aristopharma
  80. 6.14.1 Aristopharma Company Information
  81. 6.14.2 Aristopharma Business Overview
  82. 6.14.3 Aristopharma Erlotinib Generics Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Aristopharma Erlotinib Generics Product Portfolio
  84. 6.14.5 Aristopharma Recent Developments
7 North America by Country
  1. 7.1 North America Erlotinib Generics Sales by Country
  2. 7.1.1 North America Erlotinib Generics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Erlotinib Generics Sales by Country (2021-2026)
  4. 7.1.3 North America Erlotinib Generics Sales Forecast by Country (2027-2032)
  5. 7.2 North America Erlotinib Generics Market Size by Country
  6. 7.2.1 North America Erlotinib Generics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Erlotinib Generics Market Size by Country (2021-2026)
  8. 7.2.3 North America Erlotinib Generics Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Erlotinib Generics Sales by Country
  2. 8.1.1 Europe Erlotinib Generics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Erlotinib Generics Sales by Country (2021-2026)
  4. 8.1.3 Europe Erlotinib Generics Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Erlotinib Generics Market Size by Country
  6. 8.2.1 Europe Erlotinib Generics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Erlotinib Generics Market Size by Country (2021-2026)
  8. 8.2.3 Europe Erlotinib Generics Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Erlotinib Generics Sales by Country
  2. 9.1.1 Asia-Pacific Erlotinib Generics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Erlotinib Generics Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Erlotinib Generics Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Erlotinib Generics Market Size by Country
  6. 9.2.1 Asia-Pacific Erlotinib Generics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Erlotinib Generics Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Erlotinib Generics Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Erlotinib Generics Sales by Country
  2. 10.1.1 South America Erlotinib Generics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Erlotinib Generics Sales by Country (2021-2026)
  4. 10.1.3 South America Erlotinib Generics Sales Forecast by Country (2027-2032)
  5. 10.2 South America Erlotinib Generics Market Size by Country
  6. 10.2.1 South America Erlotinib Generics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Erlotinib Generics Market Size by Country (2021-2026)
  8. 10.2.3 South America Erlotinib Generics Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Erlotinib Generics Sales by Country
  2. 11.1.1 Middle East and Africa Erlotinib Generics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Erlotinib Generics Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Erlotinib Generics Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Erlotinib Generics Market Size by Country
  6. 11.2.1 Middle East and Africa Erlotinib Generics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Erlotinib Generics Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Erlotinib Generics Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Erlotinib Generics Value Chain Analysis
  2. 12.1.1 Erlotinib Generics Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Erlotinib Generics Production Mode & Process
  7. 12.2 Erlotinib Generics Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Erlotinib Generics Distributors
  10. 12.2.3 Erlotinib Generics Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst